Literature DB >> 20384814

Functional deprivation promotes amyloid plaque pathogenesis in Tg2576 mouse olfactory bulb and piriform cortex.

Xue-Mei Zhang1, Kun Xiong, Yan Cai, Huaibin Cai, Xue-Gang Luo, Jia-Chun Feng, Richard W Clough, Peter R Patrylo, Robert G Struble, Xiao-Xin Yan.   

Abstract

Cerebral hypometabolism and amyloid accumulation are principal neuropathological manifestations of Alzheimer's disease (AD). Whether and how brain/neuronal activity might modulate certain pathological processes of AD are interesting topics of recent clinical and basic research in the field, and may be of potential medical relevance in regard to both the disease etiology and intervention. Using the Tg2576 transgenic mouse model of AD, this study characterized a promotive effect of neuronal hypoactivity associated with functional deprivation on amyloid plaque pathogenesis in the olfactory pathway. Unilateral naris-occlusion caused beta-secretase-1 (BACE1) elevation in neuronal terminals in the deprived relative to the non-deprived bulb and piriform cortex in young adult mice. In parallel with the overall age-related plaque development in the forebrain, locally increased BACE1 immunoreactivity co-occurred with amyloid deposition first in the piriform cortex then within the bulb, more prominent on the deprived relative to the non-deprived side. Biochemical analyses confirmed elevated BACE1 protein levels, enzymatic activity and products in the deprived relative to non-deprived bulbs. Plaque-associated BACE1 immunoreactivity in the bulb and piriform cortex was localized preferentially to swollen/sprouting glutamatergic axonal terminals, with Abeta immunoreactivity occurring inside as well as around these terminals. Together, these findings suggest that functional deprivation or neuronal hypoactivity facilitates amyloid plaque formation in the forebrain in a transgenic model of AD, which operates synergistically with age effect. The data also implicate an intrinsic association of amyloid accumulation and plaque formation with progressive axonal pathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20384814      PMCID: PMC2861657          DOI: 10.1111/j.1460-9568.2010.07103.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  49 in total

1.  Beta-amyloid plaques induce neuritic dystrophy of nitric oxide-producing neurons in a transgenic mouse model of Alzheimer's disease.

Authors:  J Quinn; F Davis; W R Woodward; F Eckenstein
Journal:  Exp Neurol       Date:  2001-04       Impact factor: 5.330

Review 2.  Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

Authors:  D J Selkoe
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

3.  Internucleosomal DNA fragmentation during deprived and non-deprived olfactory development.

Authors:  Joseph Najbauer; Xiao-Xin Yan; Michael Leon
Journal:  Brain Res       Date:  2002-02-01       Impact factor: 3.252

4.  Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.

Authors:  R M Damian Holsinger; Catriona A McLean; Konrad Beyreuther; Colin L Masters; Geneviève Evin
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

5.  Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.

Authors:  Li-Bang Yang; Kristina Lindholm; Riqiang Yan; Martin Citron; Weiming Xia; Xiao-Li Yang; Thomas Beach; Lucia Sue; Philip Wong; Donald Price; Rena Li; Yong Shen
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

6.  Nasal airflow rate affects the sensitivity and pattern of glomerular odorant responses in the mouse olfactory bulb.

Authors:  Yuki Oka; Yoshiki Takai; Kazushige Touhara
Journal:  J Neurosci       Date:  2009-09-30       Impact factor: 6.167

7.  Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

Authors:  E M Reiman; R J Caselli; K Chen; G E Alexander; D Bandy; J Frost
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

8.  Physical activity and risk of cognitive impairment and dementia in elderly persons.

Authors:  D Laurin; R Verreault; J Lindsay; K MacPherson; K Rockwood
Journal:  Arch Neurol       Date:  2001-03

9.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

Authors:  Hiroaki Fukumoto; Bonnie S Cheung; Bradley T Hyman; Michael C Irizarry
Journal:  Arch Neurol       Date:  2002-09

10.  alpha- and beta-secretase: profound changes in Alzheimer's disease.

Authors:  Susan J Tyler; David Dawbarn; Gordon K Wilcock; Shelley J Allen
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

View more
  15 in total

1.  BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice.

Authors:  Xiao-Xin Yan; Yan Cai; Xue-Mei Zhang; Xue-Gang Luo; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  Exp Neurol       Date:  2012-01-11       Impact factor: 5.330

2.  β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.

Authors:  Yan Cai; Kun Xiong; Xue-Mei Zhang; Huaibin Cai; Xue-Gang Luo; Jia-Chun Feng; Richard W Clough; Robert G Struble; Peter R Patrylo; Yaping Chu; Jeffrey H Kordower; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2010-08-18       Impact factor: 3.386

3.  BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.

Authors:  Yan Cai; Xue-Mei Zhang; Lauren N Macklin; Huaibin Cai; Xue-Gang Luo; Salvatore Oddo; Frank M Laferla; Robert G Struble; Gregory M Rose; Peter R Patrylo; Xiao-Xin Yan
Journal:  Neurotox Res       Date:  2011-07-02       Impact factor: 3.911

4.  Apoptogenic interactions of plasmalemmal type-1 VDAC and Aβ peptides via GxxxG motifs induce Alzheimer's disease - a basic model of apoptosis?

Authors:  Friedrich P Thinnes
Journal:  Wien Med Wochenschr       Date:  2011-04-04

5.  Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury.

Authors:  Jian-Ming Li; Zhi-Qin Xue; Si-Hao Deng; Xue-Gang Luo; Peter R Patrylo; Gregory W Rose; Huaibin Cai; Yan Cai; Xiao-Xin Yan
Journal:  Neurotox Res       Date:  2012-10-05       Impact factor: 3.911

Review 6.  Can BACE1 inhibition mitigate early axonal pathology in neurological diseases?

Authors:  Xiao-Xin Yan; Chao Ma; Wei-Ping Gai; Huaibin Cai; Xue-Gang Luo
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 7.  Studies of olfactory system neural plasticity: the contribution of the unilateral naris occlusion technique.

Authors:  David M Coppola
Journal:  Neural Plast       Date:  2012-05-28       Impact factor: 3.599

8.  The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease.

Authors:  Luxiang Cao; Gregory T Rickenbacher; Steve Rodriguez; Thomas W Moulia; Mark W Albers
Journal:  Sci Rep       Date:  2012-01-20       Impact factor: 4.379

9.  Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice.

Authors:  Xiao-Xin Yan; Yan Cai; Jarod Shelton; Si-Hao Deng; Xue-Gang Luo; Salvatore Oddo; Frank M Laferla; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 10.  Consequences of inhibiting amyloid precursor protein processing enzymes on synaptic function and plasticity.

Authors:  Hui Wang; Andrea Megill; Kaiwen He; Alfredo Kirkwood; Hey-Kyoung Lee
Journal:  Neural Plast       Date:  2012-06-26       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.